{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 477238943
| IUPAC_name = 5-[2-Ethoxy-5-[2-(4-ethyl-piperazin-1-yl)-acetyl]-phenyl]-1-methyl-3-propyl-1,6-dihydro-pyrazolo[4,3-d]pyrimidin-7-one
| image = Acetildenafil.svg
| width = 250

<!--Clinical data-->
| tradename =
| MedlinePlus = a699015
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- Schedule I -->
| legal_UK = <!-- Class A -->
| legal_US = OTC
| legal_status =
| routes_of_administration = [[Oral administration|By mouth]]

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 831217-01-7
| ATC_prefix = None
| ATC_suffix =
| PubChem = 29918992
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = TP0E2BW57H
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 23976138

<!--Chemical data-->
| C=25 | H=34 | N=6 | O=3 
| molecular_weight = 466.574 g/mol
| smiles = CCCc1nn(C)c3c1nc([nH]c3=O)-c2cc(ccc2OCC)C(=O)CN4CCN(CC)CC4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C25H34N6O3/c1-5-8-19-22-23(29(4)28-19)25(33)27-24(26-22)18-15-17(9-10-21(18)34-7-3)20(32)16-31-13-11-30(6-2)12-14-31/h9-10,15H,5-8,11-14,16H2,1-4H3,(H,26,27,33)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RRBRQNALHKQCAI-UHFFFAOYSA-N
| synonyms =
}}

'''Acetildenafil''' ('''hongdenafil''') is a synthetic [[drug]] which acts as a [[phosphodiesterase inhibitor]].<ref>{{cite web | title = Acetildenafil | website = Cayman Chemical | url = https://www.caymanchem.com/product/12049 | accessdate = 26 Mar 2017}}</ref> It is an [[structural analog|analog]] of [[sildenafil]] (Viagra)<ref>{{cite journal | last1 = Blok-Tip | first1 = L | last2 = Zomer | first2 = B | last3 = Bakker | first3 = F | last4 = Hartog | first4 = KD | last5 = Hamzink | first5 = M | last6 = Ten Hove | first6 = J | last7 = Vredenbregt | first7 = M | last8 = De Kaste | first8 = D | title = Structure elucidation of sildenafil analogues in herbal products | journal = Food additives and contaminants | volume = 21 | issue = 8 | pages = 737–48 | year = 2004 | pmid = 15370823 | doi = 10.1080/02652030412331272467 }}</ref> which has been detected in numerous different brands of supposedly "herbal" aphrodisiac products sold to boost libido and alleviate [[erectile dysfunction]].<ref name= Poon >{{cite journal | last1 = Poon | first1 = WT | last2 = Lam | first2 = YH | last3 = Lai | first3 = CK | last4 = Chan | first4 = AY | last5 = Mak | first5 = TW | title = Analogues of erectile dysfunction drugs: an under-recognised threat |journal = Hong Kong Academy of Medicine | volume = 13 | issue = 5 | pages = 359–63 | year = 2007 | pmid = 17914141 }}</ref> 

A range of designer analogs of licensed [[cGMP specific phosphodiesterase type 5|PDE<sub>5</sub>]] inhibitors such as sildenafil and [[vardenafil]] have been detected in recent years in over-the-counter herbal aphrodisiac products,<ref>{{cite journal | last1 = Venhuis | first1 = B | last2 = De Kaste | first2 = D | title = Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: A history, analytical aspects and health risks. | journal = J Pharm Biomed Anal. | volume = 69 | pages = 196–208 | year = 2012 | doi=10.1016/j.jpba.2012.02.014 | pmid=22464558}}</ref><ref>{{cite journal | last1 = Zou | first1 = P | last2 = Oh | first2 = SS | last3 = Hou | first3 = P | last4 = Low | first4 = MY | last5 = Koh | first5 = HL | title = Simultaneous determination of synthetic phosphodiesterase-5 inhibitors found in a dietary supplement and pre-mixed bulk powders for dietary supplements using high-performance liquid chromatography with diode array detection and liquid chromatography-electrospray ionization tandem mass spectrometry | journal = Journal of Chromatography A | volume = 1104 | issue = 1–2 | pages = 113–22 | year = 2006 | pmid = 16364350 | doi = 10.1016/j.chroma.2005.11.103 }}</ref><ref>{{cite journal | last1 = Gratz | first1 = SR | last2 = Gamble | first2 = BM | last3 = Flurer | first3 = RA | title = Accurate mass measurement using Fourier transform ion cyclotron resonance mass spectrometry for structure elucidation of designer drug analogs of tadalafil, vardenafil and sildenafil in herbal and pharmaceutical matrices | journal = Rapid communications in mass spectrometry : RCM | volume = 20 | issue = 15 | pages = 2317–27 | year = 2006 | pmid = 16817245 | doi = 10.1002/rcm.2594 }}</ref><ref>{{cite journal | last1 = Hou | first1 = P | last2 = Zou | first2 = P | last3 = Low | first3 = MY | last4 = Chan | first4 = E | last5 = Koh | first5 = HL | title = Structural identification of a new acetildenafil analogue from pre-mixed bulk powder intended as a dietary supplement | journal = Food additives and contaminants | volume = 23 | issue = 9 | pages = 870–5 | year = 2006 | pmid = 16901855 | doi = 10.1080/02652030600803856 }}</ref> in an apparent attempt to circumvent both the legal restrictions on sale of erectile dysfunction drugs, which are [[Prescription drug|prescription-only]] medicines in most Western countries, and the [[patent]] protection which allows sale of these drugs by competitors only with permission from the patent holders (typically, under a license from the inventors) and to introduce [[efficacy]] into otherwise ineffective herbal products. These compounds have been demonstrated to display PDE<sub>5</sub> inhibitory activity ''in vitro'' and presumably have similar effects when consumed, but have undergone no formal testing in either humans or animals, and as such may represent significant health risks to consumers of these products due to their unknown safety profile.<ref name= Poon/><ref>{{cite journal | last1 = Oh | first1 = SS | last2 = Zou | first2 = P | last3 = Low | first3 = MY | last4 = Koh | first4 = HL | title = Detection of sildenafil analogues in herbal products for erectile dysfunction | journal = Journal of toxicology and environmental health. Part A | volume = 69 | issue = 21 | pages = 1951–58 | year = 2006 | pmid = 16982533 | doi = 10.1080/15287390600751355 }}</ref> Some attempts have been made to ban these drugs as unlicensed medicines, but progress has been slow so far, as even in those jurisdictions which have laws targeting designer drugs, the laws are drafted to ban analogs of illegal drugs of abuse, rather than analogs of prescription medicines. However, at least one court case has resulted in a product being taken off the market.<ref>{{cite journal | last1 = Venhuis | first1 = BJ | last2 = Blok-Tip | first2 = L | last3 = De Kaste | first3 = D | title = Designer drugs in herbal aphrodisiacs | journal = Forensic Science International | volume = 177 | issue = 2–3 | pages = e25–7 | year = 2008 | pmid = 18178354 | doi = 10.1016/j.forsciint.2007.11.007 }}</ref>

==See also==
* [[Aildenafil]]
* [[Nitrosoprodenafil]]
* [[Sulfoaildenafil]]

==References==
{{reflist}}

{{Phosphodiesterase inhibitors}}

[[Category:Aromatic ketones]]
[[Category:Designer drugs]]
[[Category:Lactams]]
[[Category:PDE5 inhibitors]]
[[Category:Phenol ethers]]
[[Category:Piperazines]]
[[Category:Pyrazolopyrimidines]]